ENZ logo

Enzo Biochem (ENZ) CAPEX

Annual CAPEX

$545.00 K
-$2.21 M-80.25%

July 31, 2024

Summary

Performance

1-Year Change

-80.25%

3-Year Change

-87.71%

5-Year Change

-93.29%

15-Year Change

-68.91%

ENZ CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

27.93%
ENZ annual capital expenditures is higher than 27.93% of companies in Healthcare sector

High & Low

All-time High

$8.90 M
ENZ annual capital expenditures is currently -93.88% below its historical high of $8.90 million

3-Year Low

$545.00 K
ENZ annual capital expenditures is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Jul 31, 2024
ENZ previous annual earnings announcement was published on Jul 31, 2024

Next Annual Earnings Report Date

N/A
ENZ next annual earnings announcement has not yet been scheduled

OtherENZcash flowmetrics:

Annual FCF

-$26.80 M
ENZ annual free cash flow is -$26.80 million

Annual CFO

-$26.26 M
ENZ annual cash flow from operations is -$26.26 million

Annual CFI

-$545.00 K
ENZ annual cash flow from investing activities is -$545.00 thousand

Annual CFF

-$4.19 M
ENZ annual cash flow from financing activities is -$4.19 million

Quarterly CAPEX

$448.00 K
+$325.00 K+264.23%

October 31, 2024

Summary

Performance

3-Month Change

+264.23%

1-Year Change

+264.23%

3-Year Change

-56.63%

5-Year Change

-27.39%

ENZ Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

46.05%
ENZ quarterly capital expenditures is higher than 46.05% of companies in Healthcare sector

High & Low

All-time High

$6.58 M
ENZ quarterly capital expenditures is currently -93.19% below its historical high of $6.58 million

3-Year Low

$25.00 K
ENZ quarterly capital expenditures is currently +1692.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Oct 31, 2024
ENZ previous earnings announcement was published on Oct 31, 2024

Next Quarterly Earnings Report Date

Mar 13, 2025
ENZ next earnings announcement is scheduled for Mar 13, 2025

OtherENZcash flowmetrics:

Quarterly FCF

-$9.44 M
ENZ quarterly free cash flow is -$9.44 million

Quarterly CFO

-$8.99 M
ENZ quarterly cash flow from operations is -$8.99 million

Quarterly CFI

$4.55 M
ENZ quarterly cash flow from investing activities is $4.55 million

Quarterly CFF

-$200.00 K
ENZ quarterly cash flow from financing activities is -$200.00 thousand

TTM CAPEX

$739.00 K
+$194.00 K+35.60%

October 31, 2024

Summary

Performance

3-Month Change

+35.6%

1-Year Change

+35.6%

3-Year Change

-84.77%

5-Year Change

-70.59%

ENZ TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

32.02%
ENZ TTM capital expenditures is higher than 32.02% of companies in Healthcare sector

High & Low

All-time High

$10.60 M
ENZ TTM capital expenditures is currently -93.03% below its historical high of $10.60 million

3-Year Low

$545.00 K
ENZ TTM capital expenditures is currently +35.60% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Oct 31, 2024
ENZ previous earnings announcement was published on Oct 31, 2024

Next Quarterly Earnings Report Date

Mar 13, 2025
ENZ next earnings announcement is scheduled for Mar 13, 2025

OtherENZcash flowmetrics:

TTM FCF

-$22.61 M
ENZ TTM free cash flow is -$22.61 million

TTM CFO

-$21.88 M
ENZ TTM cash flow from operations is -$21.88 million

TTM CFI

$4.26 M
ENZ TTM cash flow from investing activities is $4.26 million

TTM CFF

-$3.88 M
ENZ TTM cash flow from financing activities is -$3.88 million

ENZ CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-80.3%+264.2%+35.6%
3 y3 years-87.7%-56.6%-84.8%
5 y5 years-93.3%-27.4%-70.6%

ENZ CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-87.7%at low-63.1%+1692.0%-86.7%+35.6%
5 y5-year-93.3%at low-74.4%+1692.0%-86.7%+35.6%
alltimeall time-93.9%at low-93.2%+212.0%-93.0%+84.8%

Enzo Biochem CAPEX History

DateAnnualQuarterlyTTM
Oct 2024
-
$448.00 K(+264.2%)
$739.00 K(+35.6%)
Jul 2024
$545.00 K(-80.3%)
$123.00 K(-14.0%)
$545.00 K(-45.2%)
Apr 2024
-
$143.00 K(+472.0%)
$995.00 K(-34.5%)
Jan 2024
-
$25.00 K(-90.2%)
$1.52 M(-35.7%)
Oct 2023
-
$254.00 K(-55.7%)
$2.36 M(-14.4%)
Jul 2023
$2.76 M(-20.5%)
$573.00 K(-14.0%)
$2.76 M(+8.0%)
Apr 2023
-
$666.00 K(-23.4%)
$2.56 M(-6.9%)
Jan 2023
-
$869.00 K(+33.3%)
$2.75 M(-11.2%)
Oct 2022
-
$652.00 K(+76.7%)
$3.09 M(-11.0%)
Jul 2022
$3.47 M(-21.7%)
$369.00 K(-56.9%)
$3.47 M(-25.6%)
Apr 2022
-
$856.00 K(-29.5%)
$4.67 M(-16.0%)
Jan 2022
-
$1.21 M(+17.5%)
$5.56 M(+14.6%)
Oct 2021
-
$1.03 M(-34.0%)
$4.85 M(+9.4%)
Jul 2021
$4.44 M(+104.4%)
$1.57 M(-10.4%)
$4.44 M(+2.7%)
Apr 2021
-
$1.75 M(+245.3%)
$4.32 M(+51.1%)
Jan 2021
-
$506.00 K(-18.0%)
$2.86 M(+13.8%)
Oct 2020
-
$617.00 K(-57.5%)
$2.51 M(+15.8%)
Jul 2020
$2.17 M(-73.3%)
$1.45 M(+409.1%)
$2.17 M(+68.1%)
Apr 2020
-
$285.00 K(+78.1%)
$1.29 M(-17.9%)
Jan 2020
-
$160.00 K(-41.6%)
$1.57 M(-80.3%)
Oct 2019
-
$274.00 K(-52.1%)
$7.99 M(-1.6%)
Jul 2019
$8.13 M(+330.4%)
$572.00 K(+1.1%)
$8.13 M(+4.0%)
Apr 2019
-
$566.00 K(-91.4%)
$7.82 M(+0.1%)
Jan 2019
-
$6.58 M(+1521.2%)
$7.81 M(+326.1%)
Oct 2018
-
$406.00 K(+55.0%)
$1.83 M(-2.9%)
Jul 2018
$1.89 M(+7.7%)
$262.00 K(-53.2%)
$1.89 M(-3.4%)
Apr 2018
-
$560.00 K(-7.4%)
$1.96 M(-8.2%)
Jan 2018
-
$605.00 K(+31.2%)
$2.13 M(+25.3%)
Oct 2017
-
$461.00 K(+40.1%)
$1.70 M(-3.0%)
Jul 2017
$1.75 M(+14.6%)
$329.00 K(-55.2%)
$1.75 M(+12.0%)
Apr 2017
-
$735.00 K(+320.0%)
$1.56 M(+22.6%)
Jan 2017
-
$175.00 K(-66.0%)
$1.28 M(-17.1%)
Oct 2016
-
$514.00 K(+264.5%)
$1.54 M(+0.6%)
Jul 2016
$1.53 M(-14.2%)
$141.00 K(-68.4%)
$1.53 M(-23.7%)
Apr 2016
-
$446.00 K(+1.8%)
$2.00 M(-3.3%)
Jan 2016
-
$438.00 K(-13.3%)
$2.07 M(+2.4%)
Oct 2015
-
$505.00 K(-17.9%)
$2.02 M(+13.5%)
Jul 2015
$1.78 M(+112.8%)
$615.00 K(+19.4%)
$1.78 M(+24.2%)
Apr 2015
-
$515.00 K(+32.4%)
$1.44 M(+37.2%)
Jan 2015
-
$389.00 K(+47.3%)
$1.05 M(+36.3%)
Oct 2014
-
$264.00 K(-1.5%)
$768.00 K(-8.4%)
Jul 2014
$838.00 K(-15.2%)
$268.00 K(+112.7%)
$838.00 K(+6.6%)
Apr 2014
-
$126.00 K(+14.5%)
$786.00 K(-6.7%)
Jan 2014
-
$110.00 K(-67.1%)
$842.00 K(-18.3%)
Oct 2013
-
$334.00 K(+54.6%)
$1.03 M(+4.4%)
Jul 2013
$988.00 K(-27.6%)
$216.00 K(+18.7%)
$988.00 K(-14.6%)
Apr 2013
-
$182.00 K(-39.1%)
$1.16 M(-17.9%)
Jan 2013
-
$299.00 K(+2.7%)
$1.41 M(+0.5%)
Oct 2012
-
$291.00 K(-24.4%)
$1.40 M(+2.9%)
Jul 2012
$1.36 M(+11.5%)
$385.00 K(-11.5%)
$1.36 M(+15.5%)
Apr 2012
-
$435.00 K(+49.0%)
$1.18 M(-1.1%)
Jan 2012
-
$292.00 K(+15.9%)
$1.19 M(-3.2%)
Oct 2011
-
$252.00 K(+24.8%)
$1.23 M(+0.8%)
Jul 2011
$1.22 M(-62.4%)
$202.00 K(-54.9%)
$1.22 M(-28.2%)
Apr 2011
-
$448.00 K(+35.3%)
$1.70 M(-4.3%)
Jan 2011
-
$331.00 K(+36.8%)
$1.78 M(-24.7%)
Oct 2010
-
$242.00 K(-64.5%)
$2.37 M(-27.3%)
Jul 2010
$3.25 M(+20.0%)
$682.00 K(+29.9%)
$3.25 M(+4.1%)
Apr 2010
-
$525.00 K(-42.7%)
$3.12 M(-2.3%)
Jan 2010
-
$916.00 K(-18.8%)
$3.19 M(+5.2%)
Oct 2009
-
$1.13 M(+104.0%)
$3.04 M(+12.1%)
Jul 2009
$2.71 M(-16.2%)
$553.00 K(-7.5%)
$2.71 M(-28.5%)
Apr 2009
-
$598.00 K(-21.2%)
$3.79 M(+0.6%)
Jan 2009
-
$759.00 K(-5.0%)
$3.77 M(+3.9%)
Oct 2008
-
$799.00 K(-51.1%)
$3.63 M(+12.3%)
Jul 2008
$3.23 M(+123.1%)
$1.64 M(+183.4%)
$3.23 M(+63.6%)
Apr 2008
-
$577.00 K(-6.5%)
$1.98 M(-8.4%)
Jan 2008
-
$617.00 K(+53.5%)
$2.16 M(+27.5%)
Oct 2007
-
$402.00 K(+6.1%)
$1.69 M(+16.9%)
Jul 2007
$1.45 M
$379.00 K(-50.1%)
$1.45 M(-64.2%)
Apr 2007
-
$759.00 K(+399.3%)
$4.05 M(+12.8%)
DateAnnualQuarterlyTTM
Jan 2007
-
$152.00 K(-3.8%)
$3.59 M(-14.3%)
Oct 2006
-
$158.00 K(-94.7%)
$4.19 M(-0.9%)
Jul 2006
$4.23 M(+231.3%)
$2.98 M(+889.4%)
$4.23 M(+169.2%)
Apr 2006
-
$301.00 K(-59.9%)
$1.57 M(+4.0%)
Jan 2006
-
$751.00 K(+281.2%)
$1.51 M(+28.6%)
Oct 2005
-
$197.00 K(-38.6%)
$1.17 M(-8.1%)
Jul 2005
$1.28 M(-2.1%)
$321.00 K(+33.8%)
$1.28 M(-3.4%)
Apr 2005
-
$240.00 K(-42.2%)
$1.32 M(-9.5%)
Jan 2005
-
$415.00 K(+38.3%)
$1.46 M(+11.5%)
Oct 2004
-
$300.00 K(-18.0%)
$1.31 M(+0.4%)
Jul 2004
$1.30 M(+36.3%)
$366.00 K(-3.2%)
$1.30 M(+3.6%)
Apr 2004
-
$378.00 K(+42.6%)
$1.26 M(+12.9%)
Jan 2004
-
$265.00 K(-10.2%)
$1.11 M(+4.6%)
Oct 2003
-
$295.00 K(-8.0%)
$1.07 M(+11.4%)
Jul 2003
$956.70 K(+54.2%)
$320.70 K(+37.1%)
$956.70 K(+12.0%)
Apr 2003
-
$234.00 K(+8.3%)
$854.40 K(+21.3%)
Jan 2003
-
$216.00 K(+16.1%)
$704.40 K(+5.5%)
Oct 2002
-
$186.00 K(-14.8%)
$667.40 K(+7.6%)
Jul 2002
$620.40 K(-38.8%)
$218.40 K(+160.0%)
$620.40 K(-6.0%)
Apr 2002
-
$84.00 K(-53.1%)
$659.90 K(-7.0%)
Jan 2002
-
$179.00 K(+28.8%)
$709.90 K(-17.9%)
Oct 2001
-
$139.00 K(-46.1%)
$864.90 K(-14.7%)
Jul 2001
$1.01 M(+28.3%)
$257.90 K(+92.5%)
$1.01 M(+3.6%)
Apr 2001
-
$134.00 K(-59.9%)
$978.50 K(+7.2%)
Jan 2001
-
$334.00 K(+16.0%)
$912.50 K(+17.2%)
Oct 2000
-
$288.00 K(+29.4%)
$778.50 K(-1.5%)
Jul 2000
$790.50 K(-28.1%)
$222.50 K(+227.2%)
$790.50 K(-18.3%)
Apr 2000
-
$68.00 K(-66.0%)
$968.00 K(-19.3%)
Jan 2000
-
$200.00 K(-33.3%)
$1.20 M(+9.1%)
Oct 1999
-
$300.00 K(-25.0%)
$1.10 M(0.0%)
Jul 1999
$1.10 M(+83.3%)
$400.00 K(+33.3%)
$1.10 M(+10.0%)
Apr 1999
-
$300.00 K(+200.0%)
$1.00 M(+25.0%)
Jan 1999
-
$100.00 K(-66.7%)
$800.00 K(+14.3%)
Oct 1998
-
$300.00 K(0.0%)
$700.00 K(+16.7%)
Jul 1998
$600.00 K(-14.3%)
$300.00 K(+200.0%)
$600.00 K(0.0%)
Apr 1998
-
$100.00 K(>+9900.0%)
$600.00 K(0.0%)
Jan 1998
-
$0.00(-100.0%)
$600.00 K(-25.0%)
Oct 1997
-
$200.00 K(-33.3%)
$800.00 K(+14.3%)
Jul 1997
$700.00 K(0.0%)
$300.00 K(+200.0%)
$700.00 K(-12.5%)
Apr 1997
-
$100.00 K(-50.0%)
$800.00 K(0.0%)
Jan 1997
-
$200.00 K(+100.0%)
$800.00 K(+14.3%)
Oct 1996
-
$100.00 K(-75.0%)
$700.00 K(0.0%)
Jul 1996
$700.00 K(-30.0%)
$400.00 K(+300.0%)
$700.00 K(+75.0%)
Apr 1996
-
$100.00 K(0.0%)
$400.00 K(-20.0%)
Jan 1996
-
$100.00 K(0.0%)
$500.00 K(-37.5%)
Oct 1995
-
$100.00 K(0.0%)
$800.00 K(-20.0%)
Jul 1995
$1.00 M(-16.7%)
$100.00 K(-50.0%)
$1.00 M(-16.7%)
Apr 1995
-
$200.00 K(-50.0%)
$1.20 M(-14.3%)
Jan 1995
-
$400.00 K(+33.3%)
$1.40 M(+7.7%)
Oct 1994
-
$300.00 K(0.0%)
$1.30 M(+8.3%)
Jul 1994
$1.20 M(+33.3%)
$300.00 K(-25.0%)
$1.20 M(0.0%)
Apr 1994
-
$400.00 K(+33.3%)
$1.20 M(+33.3%)
Jan 1994
-
$300.00 K(+50.0%)
$900.00 K(-10.0%)
Oct 1993
-
$200.00 K(-33.3%)
$1.00 M(+11.1%)
Jul 1993
$900.00 K(-50.0%)
$300.00 K(+200.0%)
$900.00 K(-57.1%)
Apr 1993
-
$100.00 K(-75.0%)
$2.10 M(0.0%)
Jan 1993
-
$400.00 K(+300.0%)
$2.10 M(+61.5%)
Oct 1992
-
$100.00 K(-93.3%)
$1.30 M(-27.8%)
Jul 1992
$1.80 M(-72.3%)
$1.50 M(+1400.0%)
$1.80 M(+125.0%)
Apr 1992
-
$100.00 K(-125.0%)
$800.00 K(-57.9%)
Jan 1992
-
-$400.00 K(-166.7%)
$1.90 M(-51.3%)
Oct 1991
-
$600.00 K(+20.0%)
$3.90 M(-40.0%)
Jul 1991
$6.50 M(-16.7%)
$500.00 K(-58.3%)
$6.50 M(-36.3%)
Apr 1991
-
$1.20 M(-25.0%)
$10.20 M(-3.8%)
Jan 1991
-
$1.60 M(-50.0%)
$10.60 M(+1.9%)
Oct 1990
-
$3.20 M(-23.8%)
$10.40 M(+33.3%)
Jul 1990
$7.80 M(-12.4%)
$4.20 M(+162.5%)
$7.80 M(+116.7%)
Apr 1990
-
$1.60 M(+14.3%)
$3.60 M(+80.0%)
Jan 1990
-
$1.40 M(+133.3%)
$2.00 M(+233.3%)
Oct 1989
-
$600.00 K
$600.00 K
Jul 1989
$8.90 M
-
-

FAQ

  • What is Enzo Biochem annual capital expenditures?
  • What is the all time high annual CAPEX for Enzo Biochem?
  • What is Enzo Biochem annual CAPEX year-on-year change?
  • What is Enzo Biochem quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Enzo Biochem?
  • What is Enzo Biochem quarterly CAPEX year-on-year change?
  • What is Enzo Biochem TTM capital expenditures?
  • What is the all time high TTM CAPEX for Enzo Biochem?
  • What is Enzo Biochem TTM CAPEX year-on-year change?

What is Enzo Biochem annual capital expenditures?

The current annual CAPEX of ENZ is $545.00 K

What is the all time high annual CAPEX for Enzo Biochem?

Enzo Biochem all-time high annual capital expenditures is $8.90 M

What is Enzo Biochem annual CAPEX year-on-year change?

Over the past year, ENZ annual capital expenditures has changed by -$2.21 M (-80.25%)

What is Enzo Biochem quarterly capital expenditures?

The current quarterly CAPEX of ENZ is $448.00 K

What is the all time high quarterly CAPEX for Enzo Biochem?

Enzo Biochem all-time high quarterly capital expenditures is $6.58 M

What is Enzo Biochem quarterly CAPEX year-on-year change?

Over the past year, ENZ quarterly capital expenditures has changed by +$325.00 K (+264.23%)

What is Enzo Biochem TTM capital expenditures?

The current TTM CAPEX of ENZ is $739.00 K

What is the all time high TTM CAPEX for Enzo Biochem?

Enzo Biochem all-time high TTM capital expenditures is $10.60 M

What is Enzo Biochem TTM CAPEX year-on-year change?

Over the past year, ENZ TTM capital expenditures has changed by +$194.00 K (+35.60%)